» Articles » PMID: 39721821

Corrigendum to "EGFR-targeted Stearoyl Gemcitabine Nanoparticles Show Enhanced Anti-tumor Activity" [Journal of Controlled Release, 157 (2012), 287-296]

Overview
Specialty Pharmacology
Date 2024 Dec 25
PMID 39721821
Authors
Affiliations
Soon will be listed here.